-
Je něco špatně v tomto záznamu ?
Metabolic tools for identification of new mutations of enzymes engaged in purine synthesis leading to neurological impairment
M. Krijt, O. Souckova, V. Baresova, V. Skopova, M. Zikanova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Grantová podpora
NV15-28979A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
ProQuest Central
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
- MeSH
- lidé MeSH
- limita detekce MeSH
- metabolom MeSH
- metabolomika metody MeSH
- moč MeSH
- mutace genetika MeSH
- nemoci nervového systému genetika metabolismus MeSH
- puriny biosyntéza krev chemie moč MeSH
- test suché kapky krve MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The cellular pool of purines is maintained by de novo purine synthesis (DNPS), recycling and degradation. Mutations in genes encoding DNPS enzymes cause their substrates to accumulate, which has detrimental effects on cellular division and organism development, potentially leading to neurological impairments. Unspecified neurological symptoms observed in many patients could not be elucidated even by modern techniques. It is presumable that some of these problems are induced by dysfunctions in DNPS enzymes. Therefore, we determined the concentrations of dephosphorylated DNPS intermediates by LC-MS/MS as markers of yet unpublished mutations in PFAS and PAICS genes connected with dysfunctions of carboxylase/phosphoribosylaminoimidazolesuccinocarboxamide synthase (PAICS) or phosphoribosylformylglycinamidine synthase (PFAS). We determined the criteria for normal values of metabolites and investigated 1,447 samples of urine and 365 dried blood spots of patients suffering from various forms of neurological impairment. We detected slightly elevated aminoimidazole riboside (AIr) concentrations in three urine samples and a highly elevated 5-formamidoimidazole-4-carboxamide riboside (FGAr) concentration in one urine sample. The accumulation of AIr or FGAr in body fluids can indicate PAICS or PFAS deficiency, respectively, which would be new disorders of DNPS caused by mutations in the appropriate genes. Measurement of DNPS intermediates in patients with neurological symptoms can uncover the cause of serious cellular and functional impairments that are otherwise inaccessible to detection. Further genetic and molecular analysis of these patients should establish the causal mutations for prenatal diagnosis, genetic consultation, and reinforce the DNPS pathway as a therapeutic target.
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005451
- 003
- CZ-PrNML
- 005
- 20201030125308.0
- 007
- ta
- 008
- 200511s2019 xr d f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)31638562
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Krijt, Matyáš, $d 1987- $7 hka2017942408 $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 245 10
- $a Metabolic tools for identification of new mutations of enzymes engaged in purine synthesis leading to neurological impairment / $c M. Krijt, O. Souckova, V. Baresova, V. Skopova, M. Zikanova
- 504 __
- $a Literatura
- 520 9_
- $a The cellular pool of purines is maintained by de novo purine synthesis (DNPS), recycling and degradation. Mutations in genes encoding DNPS enzymes cause their substrates to accumulate, which has detrimental effects on cellular division and organism development, potentially leading to neurological impairments. Unspecified neurological symptoms observed in many patients could not be elucidated even by modern techniques. It is presumable that some of these problems are induced by dysfunctions in DNPS enzymes. Therefore, we determined the concentrations of dephosphorylated DNPS intermediates by LC-MS/MS as markers of yet unpublished mutations in PFAS and PAICS genes connected with dysfunctions of carboxylase/phosphoribosylaminoimidazolesuccinocarboxamide synthase (PAICS) or phosphoribosylformylglycinamidine synthase (PFAS). We determined the criteria for normal values of metabolites and investigated 1,447 samples of urine and 365 dried blood spots of patients suffering from various forms of neurological impairment. We detected slightly elevated aminoimidazole riboside (AIr) concentrations in three urine samples and a highly elevated 5-formamidoimidazole-4-carboxamide riboside (FGAr) concentration in one urine sample. The accumulation of AIr or FGAr in body fluids can indicate PAICS or PFAS deficiency, respectively, which would be new disorders of DNPS caused by mutations in the appropriate genes. Measurement of DNPS intermediates in patients with neurological symptoms can uncover the cause of serious cellular and functional impairments that are otherwise inaccessible to detection. Further genetic and molecular analysis of these patients should establish the causal mutations for prenatal diagnosis, genetic consultation, and reinforce the DNPS pathway as a therapeutic target.
- 650 _2
- $a test suché kapky krve $7 D059788
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a limita detekce $7 D057230
- 650 _2
- $a metabolom $7 D055442
- 650 _2
- $a metabolomika $x metody $7 D055432
- 650 _2
- $a mutace $x genetika $7 D009154
- 650 _2
- $a nemoci nervového systému $x genetika $x metabolismus $7 D009422
- 650 _2
- $a puriny $x biosyntéza $x krev $x chemie $x moč $7 D011687
- 650 _2
- $a moč $7 D014556
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Součková, Olga $7 xx0248653 $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Barešová, Veronika $7 xx0083088 $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Škopová, Václava $7 xx0248662 $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Zikánová, Marie $7 xx0248652 $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 65, č. 3 (2019), s. 152-157
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31638562 $y Pubmed
- 856 41
- $u https://fb.cuni.cz/file/5900/fb2019a0015.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y p $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20201030125306 $b ABA008
- 999 __
- $a ok $b bmc $g 1532560 $s 1095506
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 65 $c 3 $d 152-157 $e - $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- GRA __
- $a NV15-28979A $p MZ0
- LZP __
- $b NLK118 $a Pubmed-20200511